Tolerance Bio Acquired Rights to Allergy Drug TLB-33
The Philadelphia-based company secured global development and commercial rights to the monoclonal antibody.
Live Poll
Do you trust that pharmaceutical companies will use drug repurposing to prioritize patient health outcomes?